John R. Cirrito

Physiology · 2005–2019

A researcher in the Science corpus: 10 papers; trusts 1 researcher and is trusted by 2 researchers here, as inferred from the citation graph.

Subfields

• Physiology — 70 citations into it; #1,390 of 2,276 by trust here, #374 by citations

Whom John R. Cirrito trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. D. Selkoe
2. Marcus E. Raichle
3. Randy L. Buckner

Who trusts John R. Cirrito overall

1. D. Holtzman
2. J. Long
3. L. Mucke
4. J. Palop
5. Christian Haass
6. Richard O'Brien
7. Randy L. Buckner
8. Berislav Zlokovic

Papers from John R. Cirrito's perspective

Ordered by how strongly the researchers John R. Cirrito trusts endorse each paper. Same corpus, a different order for every researcher.

1. Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory (Journal of Neuroscience)
2. Alzheimer's disease: genes, proteins, and therapy. (Physiological Reviews)
3. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. (Neuron)
4. Age-Dependent Changes in Brain, CSF, and Plasma Amyloid β Protein in the Tg2576 Transgenic Mouse Model of Alzheimer's Disease (Journal of Neuroscience)
5. Searching for a baseline: Functional imaging and the resting human brain (Nature Reviews Neuroscience)
6. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. (Proceedings of the National Academy of Sciences of the United States of America)
7. RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain (Nature Medicine)
8. Molecular and electrophysiological evidence for net synaptic potentiation in wake and depression in sleep (Nature Neuroscience)
9. Variant of TREM2 Associated with the Risk of Alzheimer’s Disease (New England Journal of Medicine)
10. Multidrug resistance in cancer: role of ATP–dependent transporters (Nature Reviews. Cancer)

Their papers

• Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. (2005) — 1,291 citations
• The sleep-wake cycle regulates brain interstitial fluid tau in mice and CSF tau in humans (2019) — 707 citations
• TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques (2016) — 734 citations
• TREM2 lipid sensing sustains microglia response in an Alzheimer’s disease model (2015) — 1,505 citations
• Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer’s disease model (2012) — 633 citations
• ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models (2012) — 1,047 citations
• Neuronal activity regulates the regional vulnerability to amyloid-β deposition (2011) — 894 citations
• Amyloid-β Dynamics Are Regulated by Orexin and the Sleep-Wake Cycle (2009) — 1,359 citations
• Endocytosis is required for synaptic activity-dependent release of amyloid-beta in vivo. (2008) — 660 citations
• P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model. (2005) — 650 citations